It has been shown that targeting the amyloid precursor protein Mint2 protein–protein interaction with a peptide-based inhibitor can reduce amyloid-β formation in a neuronal model of AD (Bartling et al., 2021). This evidence concerns the gene APP and Alzheimer disease.